Importantly, Cdx2 protein expression is not confined to a particular cell lineage (James et al, 1994) , suggesting that it may be responsible for establishing regional, rather than cellular, identity in the intestinal epithelium. Furthermore, as its expression is tissue specific and present from the early embryo to the adult (James et al, 1994) , it is likely that Cdx2 plays a role in both the establishment and maintenance of the intestinal epithelial phenotype.
Human CDX2 has been localized to chromosome 13q12.3 (German et al, 1994) . Cdx2 expression was examined in human and rat colonic neoplasms, and was found to be decreased in colorectal carcinomas (CRCs) (Ee et al, 1995; Mallo et al, 1997) . In functional studies, Cdx2 has been shown to be important in the regulation of intestinal gene transcription (Suh et al, 1994) , and in the regulation of the differentiation and proliferation of intestinal cells (Suh et al, 1996) . Heterozygous null mutant mice as to Cdx2 develop multiple intestinal adenomatous polyps (Chawengsaksophak et al, 1997) , strengthening the possible relationship between Cdx2 and maintenance of the intestinal phenotype. However, it is uncertain whether or not the CDX2 gene is mutated in CRC. To address this question, we searched for CDX2 gene alterations in sporadic and hereditary non-polyposis colorectal cancer (HNPCC) CRCs.
MATERIALS AND METHODS

Subjects
A total of 49 tumours pathologically diagnosed as sporadic advanced CRC, without polyposis or a family history of HNPCC, and corresponding normal tissues were obtained by surgical or endoscopical resection. Twenty-nine CRCs were also obtained from Japanese patients that fulfilled the HNPCC criteria (Vasen et al, 1991; Muta et al, 1996) by means of surgical resection. Previous analysis of these samples demonstrated that 19 of them exhibited the microsatellite instability (MSI) phenotype. Genomic DNA was extracted from frozen tissues or paraffin-embedded tissues as described previously (Blin et al, 1976; Goelz et al, 1985) .
Determination of the exon-intron organization
The genomic structure of CDX2 was determined through the following steps. By comparing the mouse Cdx2 genomic DNA (Genbank no. U00454) and human cDNA (Genbank no. Y13709) sequences, and making use of the high homology between these sequences, we could predict the possible splicing sites in the human CDX2 genomic structure (Figure 1 ). Therefore, we designed two primer sets (for intron 1: 5′-gggctgctgcaaacgctcaacc-3′ and 5′-actcgatatttgtctttcgtcctgg-3′; and for intron 2: 5′-accaggacgaaagacaaatatcgag-3′ and 5′-acttctcagaggacctggctgag-3′) encompassing two candidate splicing sites from the human cDNA sequence, and used the human genomic DNA as a template. In addition, two other primer sets were used (primers 1U and 4D, and primers 9U and 10D in Table 1 ) to ensure that there was no unexpected splicing site. The genomic fragments encoding the human CDX2 gene were obtained by two methods. First, standard polymerase chain reaction (PCR) was performed for 30 cycles at 94°C (1 min), 55Ð68°C (2 min), and 72°C (1 min), with a final 10-min elongation at 72°C. Second, long and accurate (LA)-PCR was performed when standard PCR failed to work. For this method, 30 cycles at 94°C (30 s) and 68°C (20 min), with final elongation at 72°C, were performed, using LA-Taq polymerase (Takara, Kyoto, Japan). The PCR products were then purified using a QIA-quick spin PCR purification kit (Qiagen, Chatsworth, CA, USA), and then sequenced directly with a cycle sequencing kit (TaKaRa, Kyoto, Japan) using end-labelled primers and the conditions specified by the manufacturer.
PCR amplification of CDX2 exons 1-3 and mutation screening by PCR-SSCP (single-strand conformation polymorphism)
According to the exonÐintron boundary sequences we determined, ten sets of overlapping primers numbered 1Ð10 (5′ to 3′) were designed for all the three exons, including each splicing site of the CDX2 gene (Figure 1, Table 1 ). Non-radioisotopic PCR-SSCP analysis was performed as described previously (Oto et al, 1993) . Briefly, each PCR carried out comprised 30 cycles of denaturation for 1 min at 94°C, annealing for 2 min at 55Ð64°C and extension for 1 min at 72°C, followed by final extension for 10 min at 72°C. Dimethyl sulphoxide was added for all PCR at 5% (v/v). The PCR products and denaturing stop solution (95% formamide, 10 mM EDTA, 0.25% bromophenol blue and xylene cyanol FF) were heated at 80°C for 5 min and then cooled on ice rapidly, and then electrophoresed on non-denaturing 12.5Ð15% polyacrylamide gels containing 10% glycerol in Tris-glycine buffer (25 mM tris-HCl and 200 mM glycine, pH 8.3) using a commercially available minislab gel (90×70×1.0 mm) apparatus (Atto, Tokyo, Japan). The running conditions were 320 V for 2Ð4 h at 15°C. After electrophoresis, the gels were stained with silver (Dai-ichi, Tokyo, Japan). When abnormal patterns were observed on SSCP analysis, the PCR products were cloned into the pT7Blue(R)T-vector (Novagen, Madison, WI, USA) and sequenced as described above.
LOH (loss of heterozygosity) analysis
LOH was analysed by comparing normal and carcinoma DNA by the PCR-SSCP method.
RESULTS
Structure of the CDX2 genomic locus
The genomic structure of CDX2 was determined as described in the Materials and Methods section ( Figure 1 ). The sequencing revealed the sites and boundary sequences of each exonÐintron junction. The human CDX2 consists of three exons (541, 146 and 252 bp) separated by two introns of approximately 4.8 kb and 1.4 kb. This structure is similar to the mouse Cdx2 gene (Genbank no. U00454), except for the shorter introns in the mouse gene. The primer set designed for each exon including exonÐintron junctions is listed in Table 1 .
Mutations in CDX2
We did not observe any mutation in the entire CDX2 gene in the 49 sporadic CRC or ten HNPCC CRC without MSI on PCR-SSCP analysis. Within the CDX2 coding region, there is a seven-guanine repeat site eight codons away from the 3′ terminus. Thus, we further examined 19 HNPCC CRC exhibiting MSI in this region using primer set 10, and observed one G insertion in carcinoma 841 (Figures 2A and B) . The alteration was not found in the normal cell DNA of this cancer patient, indicating a somatic mutation. This insertion results in a frameshift with a new stop codon located 72 nucleotides downstream. As a result, the COOH-terminal eight amino acids of CDX2 are substituted with 24 different amino acids, some encoded by nucleotides normally in the 3′ untranslated region. We examined the entire CDX2 coding region in carcinoma 841, but we did not observe a second hit mutation.
Polymorphic sites and LOH analysis
The PCR-SSCP pattern of normal cell DNA showed five sequence polymorphisms in primer sets 2, 5, 8Ð9 (overlapped), and 10 (two loci) (Table 2) . Therefore, LOH analysis was carried out on these regions. The first variant, a CCG to CCC silent mutation, was detected in exon 1 codon 61. Heterozygosity was seen in 9 of the 49 (18.4%) sporadic CRC cases, and in two of the ten (20%) HNPCC cases without MSI. LOH was detected in two of the nine (22.2%) sporadic CRC informative cases, but in none of the HNPCC cases without MSI. Seven of the 48 (14.6%) healthy individuals examined exhibited such heterozygosity. The second variant, an AAC to AAG transversion in codon 164 of exon 1, changes asparagine to lysine. Only one of the 49 (2.0%) sporadic carcinoma samples showed heterozygosity at this site, however it did not exhibit LOH. Among the 48 healthy individuals examined, we found one (2.1%) individual exhibiting the same pattern. The third variant, a CCG to CTG transition in codon 260 of exon 3, changes proline to leucine. This polymorphism was located in an area in which primer sets 8 and 9 overlapped, and therefore could be detected twice. Only 2 of the 49 (4.1%) sporadic carcinoma cases were heterozygous for this area, and (Suh et al, 1994) . (B) Genomic structure of human CDX2. Boxes, exons; exon numbers in boxes, the numbers of the exons; , introns; kb, approximate lengths of the introns in kilobases; nt numbers above the boxes, nucleotide numbers corresponding to the CDX2 cDNA sequence. The 5′ boundary of exon 1 is defined by the ATG start codon, and the 3′ boundary of exon 3 by the TGA termination codon. Also shown are the sites at which PCR products were generated by using the primer sets listed in Table 1 for mutation screening (A) SSCP analysis of the (G)7 repeat site by using primer set 10. The PCR products were electrophoresed in a 12.5% polyacrylamide gel. Healthy individual DNA (H) and normal tissue (N) both showed a normal SSCP homozygous pattern. Mobility shifts were detected in carcinoma 841 (Ca), as shown by arrowheads. (B) Sequencing analysis of the CDX2 (G)7 repeat in carcinoma 841. The PCR products containing the (G)7 repeat site were cloned into a pT7Blue(R)T vector as described in the text and then sequenced. Mutant clones (MT) from carcinoma 841 showed eight guanines, (G)8, at the repeat site, whereas the corresponding normal tissue was (G)7 wild-type (WT) neither of them exhibited LOH. One of the 48 (2.1%) healthy individuals was heterozygous. The fourth variant, a TCT to CCT transition in codon 293 of exon 3 (Figure 3 ), changes serine to proline, and this heterozygous pattern was detected in 12 of the 49 (24.5%) sporadic carcinoma cases and in 16 of the 48 (33.3%) healthy individuals. One of the 12 (8.3%) informative cases exhibited LOH, and this was one of the two that exhibited LOH in codon 61. Moreover, one of the ten HNPCC cases without MSI was heterozygous and exhibited LOH at this site ( Table 2 ). The fifth variant is a silent ACC to ACT transition in codon 310 of exon 3, which was detected in one of the healthy individuals. In carcinoma 841, the one exhibiting one G insertion at the (G)7 repeat site, a second hit inactivation by LOH could not be determined because it did not present any heterozygous pattern at these polymorphic sites. Combining all the polymorphic sites in CDX2, we found two LOH in a total of the 20 (10%) informative sporadic CRC and one LOH in the three (33.3%) informative HNPCC cases.
DISCUSSION
Most sporadic CRC seem to undergo the traditional pathway of tumorigenesis (Kinzler et al, 1996) , in which one observes mutations in APC for adenoma formation, K-ras for the adenomas to become larger, and p53 for the carcinoma formation from these adenomas. In HNPCC, a so-called mutator pathway has been suggested, in which there is a germ-line mutation in one of the mismatch repair genes and a second hit in the wild-type allele would damage the DNA mismatch repair system (Hemminki et al, 1994) . Through the resultant MSI phenotype, the transforming growth factor β type II receptor gene (A)10 and apoptosis-related BAX (G)8 repeat sites have been frequently found to be mutated in HNPCC carcinomas (Markowitz et al, 1995; Rampino et al, 1997; Yagi et al, 1998) . Nevertheless, some types of CRC do not seem to undergo any of these two pathways (Yagi et al, 1997) .
Embryological studies have supported the hypothesis that the Cdx2 expression is tissue specific and present from the early embryo to the adult (James et al, 1994) , therefore it is likely that Cdx2 plays a role in both the establishment and maintenance of the intestinal epithelial phenotype. Recently, the reduction in the mRNA and protein expression in CRC (Ee et al, 1995; Mallo et al, 1997) , and the development of multiple intestinal adenomatous polyps in heterozygous null mutant mice as to Cdx2 (Chawengsaksophak et al, 1997) have strengthened the correlation of this gene and the colorectal epithelium.
We analysed the entire coding region for CDX2 in 49 sporadic advanced CRC and ten HNPCC cancers without MSI, but did not observe any mutation. However, when we examined 19 cases of HNPCC exhibiting MSI for a mutation in the seven-guanine repeat site, we observed a G somatic insertion in one case (carcinoma 841), it becoming G7/G8 heterozygous. This insertion results in a frameshift with a new stop codon located 16 amino acids downstream of the usual one. Carcinoma 841 belonged to a patient who had two synchronous CRC located in the transverse and descending colon respectively. In his family, there were eight cases of carcinomas related to HNPCC, most of which were CRC. We searched for second-hit inactivation of CDX2 in carcinoma 841, however, no alteration such as a second-hit mutation or LOH was observed. Because no germ-line mutation was found in the HNPCC cases examined, a CDX2 mutation may not be responsible for familial predisposition to cancer in HNPCC.
We observed five sequence polymorphisms in codons 61, 164, 260, 293 and 310. We did not find any discrepancy in the proportions of CDX2 homozygous and heterozygous cases in all-type carcinomas compared with healthy individuals. For codon 61, two of the nine (22.2%) informative sporadic CRC exhibited LOH. For codon 293, 1 of the 12 (8.3%) informative sporadic carcinomas exhibited LOH, and this carcinoma was one of the two that exhibited LOH in codon 61 possibly indicating one whole CDX2 allele deletion. For the remaining polymorphisms, there were only one or two informative cases. Totally, LOH was observed in 2 of the 20 (10%) and in one of the three (33.3%) informative cases in sporadic and HNPCC CRC respectively.
For codon 164, there was only one sporadic CRC case in which the sequence changed from AAC to AAG. Among the 48 healthy individuals examined, we observed such a pattern in one. Therefore, we considered it a polymorphism. However, this C to G transversion changes the predicted amino acid asparagine to lysine, and this C nucleotide is right at the 5′ extremity of the hexapeptide sequence which is a highly conserved domain and characteristic of the caudal-related family (Suh et al, 1994) . Such a polymorphism might cause some change in the function of CDX2.
In conclusion, we found only one somatic mutation and three cases of LOH in CDX2 in 78 CRC. Thus, we hypothesize that genetic alterations in the CDX2 gene may play only a minor role in sporadic and HNPCC colorectal carcinogenesis. As for the downregulation of the CDX2 mRNA and protein expression in CRC observed previously, further investigations, such as analysis of its regulatory mechanism, are necessary.
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Figure 3 LOH analysis of CRC. The PCR products of CDX2 exon 3, using primer set 10, were electrophoresed on a 12.5% polyacrylamide gel. A decrease in the number of signals is seen in carcinoma 961 (Ca), compared with the heterozygous pattern of the corresponding normal mucosa (N). H1 and H2 are representative cases of the two types of homozygous pattern
